Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Change in Cash: 2019-2021

Historic Change in Cash for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2021 value amounting to $19.2 million.

  • Black Diamond Therapeutics' Change in Cash rose 188.90% to $19.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $31.2 million, marking a year-over-year increase of 126.24%. This contributed to the annual value of -$19.8 million for FY2024, which is 191.78% down from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Change in Cash of $19.2 million as of Q4 2021, which was up 106.88% from $9.3 million recorded in Q3 2021.
  • In the past 5 years, Black Diamond Therapeutics' Change in Cash registered a high of $202.5 million during Q1 2020, and its lowest value of -$293.2 million during Q2 2020.
  • In the last 3 years, Black Diamond Therapeutics' Change in Cash had a median value of $2.1 million in 2019 and averaged $1.3 million.
  • Over the last 5 years, Black Diamond Therapeutics' Change in Cash had its largest YoY gain of 3,040.26% in 2020, and its largest YoY loss of 5,685.46% in 2020.
  • Black Diamond Therapeutics' Change in Cash (Quarterly) stood at $76.0 million in 2019, then slumped by 128.41% to -$21.6 million in 2020, then skyrocketed by 188.90% to $19.2 million in 2021.
  • Its last three reported values are $19.2 million in Q4 2021, $9.3 million for Q3 2021, and $23.2 million during Q2 2021.